Susquehanna Fundamental Investments, LLC Catalent, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $212,715 - $247,405	-1,779 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $3.18 Million - $4.14 Million	-29,085 Reduced 94.24%	1,779 $237,000
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $1.45 Million - $1.78 Million	-16,936 Reduced 35.43%	30,864 $3.21 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $3.48 Million - $4.42 Million	47,800 New	47,800 $4.1 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.